Skip to main content
Trident Lifeline Limited logo

Trident Lifeline Limited — Investor Relations & Filings

Ticker · 543616 ISIN · INE0MKA01014 LEI · 335800GZM91Q21HGZI21 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-09 Investor Presentation
Country IN India
Listing BSE.NS 543616

About Trident Lifeline Limited

https://www.tridentlifeline.com

Trident Lifeline Limited is a pharmaceutical company engaged in the manufacturing, marketing, and distribution of a wide range of pharmaceutical formulations. The company's product portfolio encompasses various therapeutic areas, including anti-infectives, analgesics, anti-inflammatory drugs, cardiovascular agents, and gastrointestinal treatments. Their dosage forms include tablets, capsules, liquid orals, and topical preparations. Trident Lifeline operates with a focus on quality compliance, adhering to international standards such as WHO-GMP. The company serves both domestic and international markets through its export operations, providing affordable healthcare solutions. Their business model integrates research and development with efficient supply chain management to deliver diverse medicinal products to healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Earnings Presentation for the half year and year ended ....
Investor Presentation Classification · 95% confidence The document is titled 'Earnings Presentation-H2 & FY26' and is addressed pursuant to SEBI regulations, indicating it is a formal disclosure related to financial results. It includes detailed company overview, product portfolio, global footprint, leadership, strategy, and financial highlights for the half year and full fiscal year ended March 31, 2026. The content is structured as a presentation with slides and detailed narrative, typical of investor presentations. It is not a brief announcement, certification, or voting result. The document length (15,000 characters) and detailed content confirm it is a presentation rather than a full annual or interim report. Therefore, the most appropriate classification is Investor Presentation (IP).
2026-05-09 English
In accordance with Regulation 47 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, we hereby enclose copies of newspaper advertisement ....
Report Publication Announcement Classification · 95% confidence The document is a letter from Trident Lifeline Limited dated May 09, 2026, addressed to BSE Limited, referencing a newspaper advertisement published on the same date. The advertisement discloses an extract of the Audited Standalone and Consolidated Financial Statements for the half year and year ended March 31, 2026. The letter states that the information is also available on the company's website. The document is essentially an announcement about the publication of financial statement extracts in newspapers, not the full financial report itself. The document length is 7070 characters, which is relatively short and consistent with an announcement rather than a full report. There is no detailed financial data or analysis included, only a notification of the advertisement and where the information can be found. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA) rather than an Interim Report (IR) or Annual Report (10-K).
2026-05-09 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.